Massi P - Search Results

1

Cannabinoids, immune system and cytokine network.

Massi P, Vaccani A, Parolaro D. Massi P, et al. Curr Pharm Des. 2006;12(24):3135-46. doi: 10.2174/138161206777947425. Curr Pharm Des. 2006. PMID: 16918439 Review.

2

Cellular mechanisms underlying the interaction between cannabinoid and opioid system.

Parolaro D, Rubino T, Viganò D, Massi P, Guidali C, Realini N. Parolaro D, et al. Among authors: massi p. Curr Drug Targets. 2010 Apr;11(4):393-405. doi: 10.2174/138945010790980367. Curr Drug Targets. 2010. PMID: 20017730 Review.

3

Endocannabinoids in the immune system and cancer.

Parolaro D, Massi P, Rubino T, Monti E. Parolaro D, et al. Among authors: massi p. Prostaglandins Leukot Essent Fatty Acids. 2002 Feb-Mar;66(2-3):319-32. doi: 10.1054/plef.2001.0355. Prostaglandins Leukot Essent Fatty Acids. 2002. PMID: 12052046 Review.

4

Cellular mechanisms of Delta 9-tetrahydrocannabinol behavioural sensitization.

Rubino T, Viganò D, Massi P, Parolaro D. Rubino T, et al. Among authors: massi p. Eur J Neurosci. 2003 Jan;17(2):325-30. doi: 10.1046/j.1460-9568.2003.02452.x. Eur J Neurosci. 2003. PMID: 12542669

5

Cannabidiol inhibits angiogenesis by multiple mechanisms.

Solinas M, Massi P, Cantelmo AR, Cattaneo MG, Cammarota R, Bartolini D, Cinquina V, Valenti M, Vicentini LM, Noonan DM, Albini A, Parolaro D. Solinas M, et al. Among authors: massi p. Br J Pharmacol. 2012 Nov;167(6):1218-31. doi: 10.1111/j.1476-5381.2012.02050.x. Br J Pharmacol. 2012. PMID: 22624859 Free PMC article.

6

CB1 receptor stimulation in specific brain areas differently modulate anxiety-related behaviour.

Rubino T, Guidali C, Vigano D, Realini N, Valenti M, Massi P, Parolaro D. Rubino T, et al. Among authors: massi p. Neuropharmacology. 2008 Jan;54(1):151-60. doi: 10.1016/j.neuropharm.2007.06.024. Epub 2007 Jul 6. Neuropharmacology. 2008. PMID: 17692344

7

Immune function alterations in mice tolerant to delta9-tetrahydrocannabinol: functional and biochemical parameters.

Massi P, Sacerdote P, Ponti W, Fuzio D, Manfredi B, Viganó D, Rubino T, Bardotti M, Parolaro D. Massi P, et al. J Neuroimmunol. 1998 Dec 1;92(1-2):60-6. doi: 10.1016/s0165-5728(98)00177-5. J Neuroimmunol. 1998. PMID: 9916880

8

Cannabinoid-precipitated withdrawal: a time-course study of the behavioral aspect and its correlation with cannabinoid receptors and G protein expression.

Rubino T, Patrini G, Massi P, Fuzio D, Viganò D, Giagnoni G, Parolaro D. Rubino T, et al. Among authors: massi p. J Pharmacol Exp Ther. 1998 May;285(2):813-9. J Pharmacol Exp Ther. 1998. PMID: 9580631

9

Changes in rat spleen cannabinoid receptors after chronic CP-55,940: an autoradiographic study.

Massi P, Patrini G, Rubino T, Fuzio D, Parolaro D. Massi P, et al. Pharmacol Biochem Behav. 1997 Sep;58(1):73-8. doi: 10.1016/s0091-3057(96)00379-6. Pharmacol Biochem Behav. 1997. PMID: 9264073

10

Chronic CP-55,940 alters cannabinoid receptor mRNA in the rat brain: an in situ hybridization study.

Rubino T, Massi P, Patrini G, Venier I, Giagnoni G, Parolaro D. Rubino T, et al. Among authors: massi p. Neuroreport. 1994 Dec 20;5(18):2493-6. doi: 10.1097/00001756-199412000-00022. Neuroreport. 1994. PMID: 7696588

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results